Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
StemFlex
- Development stage
- Unknown
- Lead developer
- StemFlex
- Modality
- Peptides, Small Molecules
- Administration
- Oral
01
Overview
StemFlex is a dietary supplement marketed as a stem cell support formula, designed to promote the mobilization of adult stem cells from the bone marrow into the peripheral circulation. Developed by StemFlex, LLC, the product contains a synergistic blend of natural ingredients, including Vitamin D3, bovine colostrum, green tea extract (rich in EGCG), L-carnosine, and blueberry extract. The proposed mechanism of action involves providing antioxidant protection to circulating stem cells and stimulating signaling pathways that facilitate the release of stem cells into the bloodstream to support the body's natural repair and regenerative processes. While marketed for joint health, anti-aging, and general wellness, it is classified as a nutraceutical and has not been approved by the FDA for the treatment of any specific disease. The name is also shared with a widely used cell culture medium for pluripotent stem cells and an orthopedic hip implant system.
- Brand names
- StemFlex
- Other names
- Stem-Flex
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on StemFlex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on StemFlex.